Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Scientific Data
|
March 3, 2023
Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer
Hongying Zhao, Xiangzhe Yin, Lixia Wang, et al.
Nucleic Acids Research
|
October 8, 2025
So3D: a comprehensive three-dimensional spatial omics resource for decoding tissue architecture in physiology and disease
Hongying Zhao, Xiangzhe Yin, Siyao Wang, et al.
International Journal of Molecular Sciences
|
May 4, 2026
Identification of Cell Subpopulation-Specific Driver Genes Reveals Ideal Candidates for Renal Cell Carcinoma Immunotherapy
Xiangzhe Yin, Lu Wang, Yanwu Sun, et al.
Journal of Translational Medicine
|
August 12, 2022
Comprehensive characterization of clonality of driver genes revealing their clinical relevance in colorectal cancer
Jian Shi, Li Wang, Xiangzhe Yin, et al.
International Journal of Molecular Sciences
|
May 27, 2026
A Multi-Omics Framework Reveals Tumor Heterogeneity and Predicts Therapeutic Targets in Renal Cell Carcinoma
Xiangzhe Yin, Zihe Zhou, Yunzhu Xue, et al.
Scientific Reports
|
June 23, 2022
Functional regulations between genetic alteration-driven genes and drug target genes acting as prognostic biomarkers in breast cancer
Li Wang, Lei Yu, Jian Shi, et al.
International Journal of Molecular Sciences
|
May 27, 2026
Identification and Characterization of Cancer-Related Risk Metabolic Subpathways Reveal Their Functional Significance in Cancer
Hongying Zhao, Jinxing Yan, Ming Wu, et al.
Nucleic Acids Research
|
November 2, 2022
LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA-target regulations in human diseases
Hongying Zhao, Xiangzhe Yin, Haotian Xu, et al.
Frontiers in Immunology
|
October 28, 2022
Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data
Hongying Zhao, Siwen Zhang, Xiangzhe Yin, et al.
Molecular Therapy. Nucleic Acids
|
December 14, 2022
The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis
Li Wang, Wangyang Liu, Kailai Liu, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Scientific Data
|
March 3, 2023
Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer
Hongying Zhao, Xiangzhe Yin, Lixia Wang, et al.
Nucleic Acids Research
|
October 8, 2025
So3D: a comprehensive three-dimensional spatial omics resource for decoding tissue architecture in physiology and disease
Hongying Zhao, Xiangzhe Yin, Siyao Wang, et al.
International Journal of Molecular Sciences
|
May 4, 2026
Identification of Cell Subpopulation-Specific Driver Genes Reveals Ideal Candidates for Renal Cell Carcinoma Immunotherapy
Xiangzhe Yin, Lu Wang, Yanwu Sun, et al.
Journal of Translational Medicine
|
August 12, 2022
Comprehensive characterization of clonality of driver genes revealing their clinical relevance in colorectal cancer
Jian Shi, Li Wang, Xiangzhe Yin, et al.
International Journal of Molecular Sciences
|
May 27, 2026
A Multi-Omics Framework Reveals Tumor Heterogeneity and Predicts Therapeutic Targets in Renal Cell Carcinoma
Xiangzhe Yin, Zihe Zhou, Yunzhu Xue, et al.
Scientific Reports
|
June 23, 2022
Functional regulations between genetic alteration-driven genes and drug target genes acting as prognostic biomarkers in breast cancer
Li Wang, Lei Yu, Jian Shi, et al.
International Journal of Molecular Sciences
|
May 27, 2026
Identification and Characterization of Cancer-Related Risk Metabolic Subpathways Reveal Their Functional Significance in Cancer
Hongying Zhao, Jinxing Yan, Ming Wu, et al.
Nucleic Acids Research
|
November 2, 2022
LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA-target regulations in human diseases
Hongying Zhao, Xiangzhe Yin, Haotian Xu, et al.
Frontiers in Immunology
|
October 28, 2022
Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data
Hongying Zhao, Siwen Zhang, Xiangzhe Yin, et al.
Molecular Therapy. Nucleic Acids
|
December 14, 2022
The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis
Li Wang, Wangyang Liu, Kailai Liu, et al.
Page
of 1